P1‐283: ROUTINE CLINICAL USE OF MASS SPECTROMETRY FOR QUANTIFICATION OF AMYLOID‐β 1‐40 AND 1‐42: PRE‐ANALYTICAL AND ANALYTICAL CONSIDERATIONS. (1st July 2006)